Is CBD a narcotic

EU Commission evaluates CBD as a narcotic

“From the point of view of the BVL, either an application for approval of a drug or an application for approval of a novel food must be submitted for products containing CBD before they can be placed on the market,” the Federal Office announced last year. In fact, none of the products available in Germany meet this requirement - they are therefore not marketable for the BVL.

However, if you are trying to get your CBD product approved as a novel food by the European Commission, you have bad cards at the moment. A few days ago, the commission announced that around 50 such applications had been put on hold for the time being. It is based on a regulation that is almost 60 years old. She is "provisionally of the opinion that CBD, which is produced from the flowering and fruit-bearing tips of the hemp plant (Cannabis sativa L.) should be considered a narcotic under the United Nations Single Convention on Narcotic Drugs of 1961 ”. However, a product cannot be both a narcotic and a food product. The applicants now have the opportunity to comment on this for the time being.

In Germany, on the other hand, CBD products are not subject to the Narcotics Act if their tetrahydrocannabinol (THC) content does not exceed 0.2 percent. CBD is obtained from female plants and mainly from industrial hemp species that hardly contain THC, but small amounts are usually present in the extracts. It is therefore unclear what it would mean if the Commission stuck to its position.